MUCUS RELIEF- guaifenesin 400 mg tablet 
Pioneer Life Sciences, LLC

----------

MUCUS RELIEF- Guaifenesin 400 mg tablet

Active ingredient (in each tablet)

Guaifenesin 400 mg

Purpose

Expectorant

Uses

Warnings

Do not use: for children under 12 years of age

Ask a doctor before use if you have

Stop use and ask a doctor if

If pregnant or breast-feeding,ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.

Directions

Other information

Inactive ingredients

Maltodextrin, Povidone, Microcrystalline cellulose, Croscarmellose sodium, Stearic acid, Magnesium sterate, Silicone dioxide.

Questions or Comments ?

Call +1 (732) 994-2808 or email support@gencare.health

This product is not manufcatured or distributed by Reckitt Benckiser's , owner of the Registered Trademark MUCINEX®

Distributed by: GenCare Consumer Products, LLC

40E Cotters Ln Suite A, East Brunswick, NJ 08816

PL0217-Mucus Relief Regular Strength 200ct_Health Pharma

MUCUS RELIEF 
guaifenesin 400 mg tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72090-019
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN400 mg
Inactive Ingredients
Ingredient NameStrength
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
POVIDONE (UNII: FZ989GH94E)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Product Characteristics
ColorwhiteScoreno score
Shapecapsule (CAPLET) Size14mm
FlavorImprint Code G400
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72090-019-01200 in 1 BOTTLE; Type 0: Not a Combination Product06/11/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01206/11/2024
Labeler - Pioneer Life Sciences, LLC (014092742)

Revised: 6/2024
Document Id: cb15baa7-6256-4a19-92bb-4ed97529acbf
Set id: 8188b66a-5405-4e62-bde6-63ebc1f22b16
Version: 1
Effective Time: 20240611
 
Pioneer Life Sciences, LLC